📰 Biotools Inc News
Page 2 - Biotools Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biotools Inc. Real-time updates on events, politics, business and more.
October 17, 2023
Standard BioTools Inc. (NASDAQ:LAB – Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totalling 3,520,000 shares, a growth of 28.5% from the September 15th total of 2,740,000 shares. Approximately 4.6% of the shares of the stock are short sold. Based […]
September 29, 2023
Quanterix (NASDAQ:QTRX – Get Free Report) and Standard BioTools (NASDAQ:LAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Institutional & Insider Ownership 86.6% of Quanterix shares […]
August 30, 2023
Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) and Standard BioTools (NASDAQ:LAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability. Institutional & Insider Ownership 51.7% of […]
July 12, 2023
KeyBanc Capital Markets initiated coverage on Standard BioTools Inc (NASDAQ: LAB) with an Overweight rating and a 
June 17, 2023
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 2,780,000 shares, a decline of 12.0% from the May 15th total of 3,160,000 shares. Currently, 3.7% of the company’s shares are sold short. Based […]
May 25, 2023
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black acquired 43,492 shares of the firm’s stock in a transaction on Thursday, May 18th. The shares were purchased at an average cost of $2.22 per share, for a total transaction of $96,552.24. Following the completion of the purchase, the chief financial officer now directly […]
May 23, 2023
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black bought 43,492 shares of the firm’s stock in a transaction dated Thursday, May 18th. The shares were bought at an average price of $2.22 per share, with a total value of $96,552.24. Following the completion of the transaction, the chief financial officer now directly […]
April 29, 2023
Susquehanna International Group LLP raised its position in shares of Standard BioTools Inc. (NASDAQ:LAB – Get Rating) by 189.5% in the fourth quarter, Holdings Channel reports. The fund owned 43,137 shares of the company’s stock after buying an additional 28,237 shares during the quarter. Susquehanna International Group LLP’s holdings in Standard BioTools were worth $50,000 […]
April 2, 2023
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 2,600,000 shares, a decrease of 15.0% from the February 28th total of 3,060,000 shares. Based on an average daily trading volume, of 246,200 shares, […]